{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T03:36:18Z","timestamp":1791948978035,"version":"4.3.4"},"reference-count":13,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T00:00:00Z","timestamp":1609891200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008040","name":"Kao Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008040","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.jtct.2020.12.027","type":"journal-article","created":{"date-parts":[[2020,12,31]],"date-time":"2020-12-31T21:07:51Z","timestamp":1609448871000},"page":"504.e1-504.e6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":71,"title":["Epidemiology and Treatment of Chronic Graft-versus-Host Disease Post-Allogeneic Hematopoietic Cell Transplantation: A US Claims Analysis"],"prefix":"10.1016","volume":"27","author":[{"given":"Carlos R.","family":"Bachier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay K.","family":"Aggarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalin","family":"Hennegan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Milgroom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Francis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumudu","family":"Dehipawala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Rotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtct.2020.12.027_bib0001","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.bbmt.2014.10.021","article-title":"Graft-vs-Host Disease Working Committee of the CIBMTR. Increasing incidence of chronic graft-versus-host disease in allogeneic transplantation: a report from the Center for International Blood and Marrow Transplant Research","volume":"21","author":"Arai","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2020.12.027_bib0002","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1053\/bbmt.2003.50026","article-title":"Chronic graft-versus-host disease","volume":"9","author":"Lee","year":"2003","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2020.12.027_bib0003","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1056\/NEJM199907013410103","article-title":"Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry","volume":"341","author":"Soci\u00e9","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtct.2020.12.027_bib0004","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/bmt.2015.195","article-title":"Physical function and quality of life in patients with chronic graft-versus-host-disease: a summary of preclinical and clinical studies and a call for exercise intervention trials in patients","volume":"51","author":"Fiuza-Luces","year":"2016","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2020.12.027_bib0005","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1182\/blood-2014-08-551994","article-title":"How we treat chronic graft-versus-host disease","volume":"125","author":"Flowers","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2020.12.027_bib0006","unstructured":"U.S. Food and Drug Administration (FDA). FDA expands ibrutinib indications to chronic GVHD. Available at: https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-expands-ibrutinib-indications-chronic-gvhd. Accessed October 21, 2020"},{"key":"10.1016\/j.jtct.2020.12.027_bib0007","unstructured":"D'Souza A, Fretham C.Current uses and outcomes of hematopoietic cell transplantation (HCT): CIBMTR Summary Slides, 2018. Available at: https:\/\/www.cibmtr.org. Accessed October 21, 2020"},{"key":"10.1016\/j.jtct.2020.12.027_bib0008","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2147\/CLEP.S105613","article-title":"Use of the Medicare database in epidemiologic and health services research: a valuable source of real-world evidence on the older and disabled populations in the US","volume":"9","author":"Mues","year":"2017","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.jtct.2020.12.027_bib0009","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1053\/j.gastro.2008.09.012","article-title":"Direct health care costs of Crohn's disease and ulcerative colitis in US children and adults","volume":"135","author":"Kappelman","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jtct.2020.12.027_bib0010","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/phar.2427","article-title":"Evolving therapeutic options for chronic graft-versus-host disease","volume":"40","author":"Gonzalez","year":"2020","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jtct.2020.12.027_bib0011","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1377\/hlthaff.2017.1299","article-title":"The National Health Expenditure Accounts Team. National health care spending in 2016: spending and enrollment growth slow after initial coverage expansions","volume":"37","author":"Hartman","year":"2018","journal-title":"Health Aff (Millwood)"},{"key":"10.1016\/j.jtct.2020.12.027_bib0012","unstructured":"Incyte Corporation. Jakafi: Highlights of prescribing information. 2020. Available at: https:\/\/www.jakafi.com\/pdf\/prescribing-information.pdf. Accessed October 21, 2020"},{"key":"10.1016\/j.jtct.2020.12.027_bib0013","unstructured":"Centers for Medicare and Medicaid Services. Data Analysis Brief: Medicare-Medicaid Dual Enrollment 2006 through 2017. Available at: https:\/\/www.cms.gov\/Medicare-Medicaid-Coordination\/Medicare-and-Medicaid-Coordination\/Medicare-Medicaid-Coordination-Office\/DataStatisticalResources\/Downloads\/MedicareMedicaidDualEnrollmentEverEnrolledTrendsDataBrief2006-2017.pdf. Accessed October 21, 2020"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636720301019?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636720301019?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T00:10:37Z","timestamp":1725322237000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636720301019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":13,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S2666636720301019"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2020.12.027","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epidemiology and Treatment of Chronic Graft-versus-Host Disease Post-Allogeneic Hematopoietic Cell Transplantation: A US Claims Analysis","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2020.12.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}